Sygnature Discovery Ltd

United Kingdom

Back to Profile

1-8 of 8 for Sygnature Discovery Ltd Sort by
Query
Aggregations
IP Type
        Trademark 6
        Patent 2
Jurisdiction
        World 4
        Canada 2
        United States 2
Date
2024 November 2
2024 6
2022 1
2020 1
IPC Class
C07D 311/24 - Benzo [b] pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2 2
C07D 405/12 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links 2
C07D 405/14 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings 2
A61P 25/00 - Drugs for disorders of the nervous system 1
A61P 35/00 - Antineoplastic agents 1
See more
NICE Class
01 - Chemical and biological materials for industrial, scientific and agricultural use 6
40 - Treatment of materials; recycling, air and water treatment, 6
42 - Scientific, technological and industrial services, research and design 6
Status
Pending 4
Registered / In Force 4

1.

SYGNATURE DISCOVERY

      
Application Number 1825452
Status Registered
Filing Date 2024-09-27
Registration Date 2024-09-27
Owner Sygnature Discovery Limited (United Kingdom)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 40 - Treatment of materials; recycling, air and water treatment,
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Proteins for use in industry; proteins for use in manufacture; proteins for use in science; proteins for use in the manufacture of pharmaceutical products; raw proteins; raw proteins for use in industry; raw proteins for use in manufacture; raw proteins for use in science; raw proteins for use in the manufacture of pharmaceutical products. Processing of organic chemical liquids; recycling of organic solvents; purification of proteins; purification of proteins by chemical methods. Scientific research and development services; drug discovery services; development of pharmaceutical preparations and medicines; drug screening for scientific purposes; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of drugs; research relating to medicines; services for assessing the efficacy of drugs; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and developments; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; proving medical and scientific research information in the field of pharmaceuticals and drug development; research and development in the pharmaceutical and drug development fields; testing of pharmaceutical drugs; assay development services; biological research; biological analysis; biological development services; biological laboratory services; biological research, clinical research and medical research; consultancy relating to pharmacology; medical and pharmacological research services; scientific research for medical purposes; research in the field of synthetic biology; research and development in the field of microorganisms and cells; chemical research and analysis services; chemical engineering; chemistry services; medicinal, synthetic, analytical and high throughput chemistry services; clinical research; organic chemistry research and analysis services; consultancy in the field of organic chemistry; laboratory research and analysis services in the field of organic chemistry; research and development services in the field of organic chemistry; development, testing and analysis of chemicals; development, testing and analysis of chemical production methods; protein and peptide mapping for scientific purposes; scientific analysis services; protein analysis services for scientific purposes; protein sequencing research; protein crystallisation screening for scientific purposes; quality control; testing of materials; testing of products; technological research; industrial analysis and research services; scientific services relating to cell line generation; scientific screening services; compound profiling and selectivity services; X-ray imaging, other than for medical purposes; blood analysis services; blood analysis services for scientific research purposes; information, advisory and consultancy services relating to the aforesaid services.

2.

SYGNATURE DISCOVERY

      
Application Number 1823673
Status Registered
Filing Date 2024-09-12
Registration Date 2024-09-12
Owner Sygnature Discovery Limited (United Kingdom)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 40 - Treatment of materials; recycling, air and water treatment,
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Proteins for use in industry; proteins for use in manufacture; proteins for use in science; proteins for use in the manufacture of pharmaceutical products; raw proteins; raw proteins for use in industry; raw proteins for use in manufacture; raw proteins for use in science; raw proteins for use in the manufacture of pharmaceutical products. Processing of organic chemical liquids; recycling of organic solvents; purification of proteins; purification of proteins by chemical methods. Scientific research and development services; drug discovery services; development of pharmaceutical preparations and medicines; drug screening for scientific purposes; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of drugs; research relating to medicines; services for assessing the efficacy of drugs; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and developments; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; proving medical and scientific research information in the field of pharmaceuticals and drug development; research and development in the pharmaceutical and drug development fields; testing of pharmaceutical drugs; assay development services; biological research; biological analysis; biological development services; biological laboratory services; biological research, clinical research and medical research; consultancy relating to pharmacology; medical and pharmacological research services; scientific research for medical purposes; research in the field of synthetic biology; research and development in the field of microorganisms and cells; chemical research and analysis services; chemical engineering; chemistry services; medicinal, synthetic, analytical and high throughput chemistry services; clinical research; organic chemistry research and analysis services; consultancy in the field of organic chemistry; laboratory research and analysis services in the field of organic chemistry; research and development services in the field of organic chemistry; development, testing and analysis of chemicals; development, testing and analysis of chemical production methods; protein and peptide mapping for scientific purposes; scientific analysis services; protein analysis services for scientific purposes; protein sequencing research; protein crystallisation screening for scientific purposes; quality control; testing of materials; testing of products; technological research; industrial analysis and research services; scientific services relating to cell line generation; scientific screening services; compound profiling and selectivity services; X-ray imaging, other than for medical purposes; blood analysis services; blood analysis services for scientific research purposes; information, advisory and consultancy services relating to the aforesaid services.

3.

SYGNATURE DISCOVERY

      
Application Number 236512600
Status Pending
Filing Date 2024-09-27
Owner Sygnature Discovery Limited (United Kingdom)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 40 - Treatment of materials; recycling, air and water treatment,
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

(1) Proteins for use in industry; proteins for use in manufacture; proteins for use in science; proteins for use in the manufacture of pharmaceutical products; raw proteins; raw proteins for use in industry; raw proteins for use in manufacture; raw proteins for use in science; raw proteins for use in the manufacture of pharmaceutical products. (1) Processing of organic chemical liquids; recycling of organic solvents; purification of proteins; purification of proteins by chemical methods. (2) Scientific research and development services; drug discovery services; development of pharmaceutical preparations and medicines; drug screening for scientific purposes; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of drugs; research relating to medicines; services for assessing the efficacy of drugs; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and developments; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; proving medical and scientific research information in the field of pharmaceuticals and drug development; research and development in the pharmaceutical and drug development fields; testing of pharmaceutical drugs; assay development services; biological research; biological analysis; biological development services; biological laboratory services; biological research, clinical research and medical research; consultancy relating to pharmacology; medical and pharmacological research services; scientific research for medical purposes; research in the field of synthetic biology; research and development in the field of microorganisms and cells; chemical research and analysis services; chemical engineering; chemistry services; medicinal, synthetic, analytical and high throughput chemistry services; clinical research; organic chemistry research and analysis services; consultancy in the field of organic chemistry; laboratory research and analysis services in the field of organic chemistry; research and development services in the field of organic chemistry; development, testing and analysis of chemicals; development, testing and analysis of chemical production methods; protein and peptide mapping for scientific purposes; scientific analysis services; protein analysis services for scientific purposes; protein sequencing research; protein crystallisation screening for scientific purposes; quality control; testing of materials; testing of products; technological research; industrial analysis and research services; scientific services relating to cell line generation; scientific screening services; compound profiling and selectivity services; X-ray imaging, other than for medical purposes; blood analysis services; blood analysis services for scientific research purposes; information, advisory and consultancy services relating to the aforesaid services.

4.

SYGNATURE DISCOVERY

      
Serial Number 79411026
Status Pending
Filing Date 2024-09-27
Owner Sygnature Discovery Limited (United Kingdom)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 40 - Treatment of materials; recycling, air and water treatment,
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Proteins for use in industry; proteins for use in manufacture; proteins for use in science; proteins for use in the manufacture of pharmaceutical products; raw proteins; raw proteins for use in industry; raw proteins for use in manufacture; raw proteins for use in science; raw proteins for use in the manufacture of pharmaceutical products. Processing of organic chemical liquids; recycling of organic solvents; purification of proteins; purification of proteins by chemical methods. Scientific research and development services; drug discovery services; development of pharmaceutical preparations and medicines; drug screening for scientific purposes; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of drugs; research relating to medicines; services for assessing the efficacy of drugs; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and developments; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; proving medical and scientific research information in the field of pharmaceuticals and drug development; research and development in the pharmaceutical and drug development fields; testing of pharmaceutical drugs; assay development services; biological research; biological analysis; biological development services; biological laboratory services; biological research, clinical research and medical research; consultancy relating to pharmacology; medical and pharmacological research services; scientific research for medical purposes; research in the field of synthetic biology; research and development in the field of microorganisms and cells; chemical research and analysis services; chemical engineering; chemistry services; medicinal, synthetic, analytical and high throughput chemistry services; clinical research; organic chemistry research and analysis services; consultancy in the field of organic chemistry; laboratory research and analysis services in the field of organic chemistry; research and development services in the field of organic chemistry; development, testing and analysis of chemicals; development, testing and analysis of chemical production methods; protein and peptide mapping for scientific purposes; scientific analysis services; protein analysis services for scientific purposes; protein sequencing research; protein crystallisation screening for scientific purposes; quality control; testing of materials; testing of products; technological research; industrial analysis and research services; scientific services relating to cell line generation; scientific screening services; compound profiling and selectivity services; X-ray imaging, other than for medical purposes; blood analysis services; blood analysis services for scientific research purposes; information, advisory and consultancy services relating to the aforesaid services.

5.

SYGNATURE DISCOVERY

      
Serial Number 79410216
Status Pending
Filing Date 2024-09-12
Owner Sygnature Discovery Limited (United Kingdom)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 40 - Treatment of materials; recycling, air and water treatment,
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Proteins for use in industry; proteins for use in manufacture; proteins for use in science; proteins for use in the manufacture of pharmaceutical products; raw proteins; raw proteins for use in industry; raw proteins for use in manufacture; raw proteins for use in science; raw proteins for use in the manufacture of pharmaceutical products. Processing of organic chemical liquids; recycling of organic solvents; purification of proteins; purification of proteins by chemical methods. Scientific research and development services; drug discovery services; development of pharmaceutical preparations and medicines; drug screening for scientific purposes; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of drugs; research relating to medicines; services for assessing the efficacy of drugs; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and developments; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; proving medical and scientific research information in the field of pharmaceuticals and drug development; research and development in the pharmaceutical and drug development fields; testing of pharmaceutical drugs; assay development services; biological research; biological analysis; biological development services; biological laboratory services; biological research, clinical research and medical research; consultancy relating to pharmacology; medical and pharmacological research services; scientific research for medical purposes; research in the field of synthetic biology; research and development in the field of microorganisms and cells; chemical research and analysis services; chemical engineering; chemistry services; medicinal, synthetic, analytical and high throughput chemistry services; clinical research; organic chemistry research and analysis services; consultancy in the field of organic chemistry; laboratory research and analysis services in the field of organic chemistry; research and development services in the field of organic chemistry; development, testing and analysis of chemicals; development, testing and analysis of chemical production methods; protein and peptide mapping for scientific purposes; scientific analysis services; protein analysis services for scientific purposes; protein sequencing research; protein crystallisation screening for scientific purposes; quality control; testing of materials; testing of products; technological research; industrial analysis and research services; scientific services relating to cell line generation; scientific screening services; compound profiling and selectivity services; X-ray imaging, other than for medical purposes; blood analysis services; blood analysis services for scientific research purposes; information, advisory and consultancy services relating to the aforesaid services.

6.

SYGNATURE DISCOVERY

      
Application Number 236347200
Status Pending
Filing Date 2024-09-12
Owner Sygnature Discovery Limited (United Kingdom)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 40 - Treatment of materials; recycling, air and water treatment,
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

(1) Proteins for use in industry; proteins for use in manufacture; proteins for use in science; proteins for use in the manufacture of pharmaceutical products; raw proteins; raw proteins for use in industry; raw proteins for use in manufacture; raw proteins for use in science; raw proteins for use in the manufacture of pharmaceutical products. (1) Processing of organic chemical liquids; recycling of organic solvents; purification of proteins; purification of proteins by chemical methods. (2) Scientific research and development services; drug discovery services; development of pharmaceutical preparations and medicines; drug screening for scientific purposes; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of drugs; research relating to medicines; services for assessing the efficacy of drugs; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and developments; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; proving medical and scientific research information in the field of pharmaceuticals and drug development; research and development in the pharmaceutical and drug development fields; testing of pharmaceutical drugs; assay development services; biological research; biological analysis; biological development services; biological laboratory services; biological research, clinical research and medical research; consultancy relating to pharmacology; medical and pharmacological research services; scientific research for medical purposes; research in the field of synthetic biology; research and development in the field of microorganisms and cells; chemical research and analysis services; chemical engineering; chemistry services; medicinal, synthetic, analytical and high throughput chemistry services; clinical research; organic chemistry research and analysis services; consultancy in the field of organic chemistry; laboratory research and analysis services in the field of organic chemistry; research and development services in the field of organic chemistry; development, testing and analysis of chemicals; development, testing and analysis of chemical production methods; protein and peptide mapping for scientific purposes; scientific analysis services; protein analysis services for scientific purposes; protein sequencing research; protein crystallisation screening for scientific purposes; quality control; testing of materials; testing of products; technological research; industrial analysis and research services; scientific services relating to cell line generation; scientific screening services; compound profiling and selectivity services; X-ray imaging, other than for medical purposes; blood analysis services; blood analysis services for scientific research purposes; information, advisory and consultancy services relating to the aforesaid services.

7.

MODULATORS OF THE INTEGRATED STRESS PATHWAY

      
Application Number US2021057300
Publication Number 2022/094244
Status In Force
Filing Date 2021-10-29
Publication Date 2022-05-05
Owner
  • CALICO LIFE SCIENCES LLC (USA)
  • ABBVIE INC. (USA)
  • SYGNATURE DISCOVERY LIMITED (United Kingdom)
Inventor
  • Martin, Kathleen, Ann
  • Sidrauski, Carmela
  • Dart, Michael, J.
  • Murauski, Kathleen, J.
  • Randolph, John, T.
  • Shi, Lei
  • Smith, Russell, C.
  • Tong, Yunsong
  • Xu, Xiangdong
  • Benelkebir, Hanae
  • Chohan, Kamaldeep, K.
  • Edeson, Steven, J.
  • Schwenk, Sebastian
  • Starbuck, Kathryn, A.

Abstract

Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (I SR) and for treating related diseases, disorders, and conditions.

IPC Classes  ?

  • C07D 231/12 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
  • C07D 231/18 - One oxygen or sulfur atom
  • C07D 231/20 - One oxygen atom attached in position 3 or 5
  • C07D 231/56 - BenzopyrazolesHydrogenated benzopyrazoles
  • C07D 311/24 - Benzo [b] pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
  • C07D 405/12 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
  • C07D 405/14 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
  • C07D 413/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
  • C07D 413/14 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
  • C07D 471/04 - Ortho-condensed systems
  • C07D 213/64 - One oxygen atom attached in position 2 or 6
  • C07D 249/04 - 1,2,3-TriazolesHydrogenated 1,2,3-triazoles
  • C07D 401/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring- member bond
  • C07D 401/06 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
  • C07D 403/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings directly linked by a ring-member-to-ring- member bond

8.

SUBSTITUTED CYCLOLAKYLS AS MODULATORS OF THE INTEGRATED STRESS PATHWAY

      
Application Number US2020030817
Publication Number 2020/223536
Status In Force
Filing Date 2020-04-30
Publication Date 2020-11-05
Owner
  • CALICO LIFE SCIENCES LLC (USA)
  • ABBVIE INC. (USA)
  • SYGNATURE DISCOVERY LIMITED (United Kingdom)
Inventor
  • Martin, Kathleen, Ann
  • Sidrauski, Carmela
  • Frost, Jennifer, M.
  • Tong, Yunsong
  • Xu, Xiangdong
  • Chung, Seungwon
  • Zhang, Qingwei, I.
  • Shi, Lei
  • Murauski, Kathleen, J.
  • Dart, Michael, J.
  • Randolph, John, T.
  • Benelkebir, Hanae

Abstract

Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases, disorders and conditions.

IPC Classes  ?

  • C07D 265/36 - 1,4-OxazinesHydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
  • A61P 25/00 - Drugs for disorders of the nervous system
  • A61P 35/00 - Antineoplastic agents
  • A61P 37/00 - Drugs for immunological or allergic disorders
  • C07C 1/00 - Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
  • C07D 209/08 - IndolesHydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
  • C07D 217/16 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
  • C07D 307/85 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
  • C07D 311/24 - Benzo [b] pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
  • C07D 311/68 - Benzo [b] pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulfur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
  • C07D 317/68 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
  • C07D 319/20 - 1,4-DioxanesHydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
  • C07D 405/12 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
  • C07D 405/14 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
  • C07D 413/06 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms